Drugs Made In America Acq... (DMAA)
NasdaqGM: DMAA
· Echtzeitkurs · USD
10.69
+0.00 (0.00%)
Zum Schluss: Aug 10, 2026, 3:54 PM
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Analysis & Data
0.00% (1D)
| Geld | 10.65 |
| Marktkapitalisierung | 259.52 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | 6.66 Mio |
| Beta | n/a |
| EPS (ttm) | 0.2 |
| KGV (TTM) | 53.45 |
| Forward-KGV | n/a |
| KBV (TTM) | -48.81 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 10.54 |
| Volumen | 6 |
| Ø Vol. (20D) | 35,238 |
| Eröffnung | 10.69 |
| Vortagesschluss | 10.69 |
| Tagesspanne | 10.69 - 10.69 |
| 52-Wk Range | 10.22 - 10.72 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über DMAA
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York....
Branche Shell Companies
Sektor Financial Services
IPO Datum Feb 25, 2025
Mitarbeiter n/a
Börse NasdaqGM
Tickersymbol DMAA
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Drugs Made In America Acquisition 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei 5.94 Mio, ein Anstieg von undefined %.
Finanzberichte